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Natural and vaccine-induced  virus infections often are associated with depres- 
sion of delayed-type hypersensitivity (DTH),' T-helper cell function, and the in 
vitro proliferative response of lymphocytes  to antigens and phytohemagglutinin 
(1-3).  The underlying mechanisms are complex and have not yet been fully 
elucidated. However, in certain myxo- and paramyxovirus infections, unrespon- 
siveness seems to be related, in part, to virus-induced changes in T-lymphocyte 
traffic (4,  5).  When injected intravenously (i.v.)  into rats or mice, Newcastle 
disease virus (NDV) causes transient lymphocytepenia  and depletion of lympho- 
cytes in the thymus-dependent  areas of lymphoid tissue (6). Lymphocyte  output 
from the thoracic duct is depressed, but recovery occurs within 72 h after virus 
injection.  These changes are related in  some way to  adsorption of NDV  to 
recirculating  T cells. It is in keeping with this view that lymphocytopenia  occurs 
in  mice  injected with  ultraviolet-irradiated NDV  (UV-NDV)  which  cannot 
achieve a complete replication cycle in embryonated eggs (6). 
The results of the current investigation confirm and extend these observations 
by showing that NDV has a  transient influence on T-cell traffic into lymph 
nodes and inflammatory foci. Cell migration is distorted after brief exposure of 
thoracic duct lymphocytes (TDL) in vitro to either infectious NDV (I-NDV) or 
UV-NDV  before i.v.  injection into  syngeneic rats.  But  I-NDV  has  another 
lasting effect upon  antigen-activated T  cells which cannot be  duplicated by 
irradiated virus. It is revealed in the ability of infectious virus to abrogate the 
protective immunity and DTH transferred by TDL obtained from rats infected 
with Listeria monocytogenes.  The inhibitory influence of I-NDV is reflected in 
permanent exclusion of labeled  S-phase  lymphocytes from Listeria-induced 
exudates. These effects are observed after treatment of the cells with low virus 
multiplicities. The mechanism has not been determined; however, there are 
reasons for thinking that activated T cells are especially vulnerable to I-NDV 
because they alone provide the appropriate milieu for virus replication (7). 
* Supported by grant IM-6E from the American Cancer Society and grant CA 15420 from the 
National Cancer Institute. 
1  Abbreviations  used in this paper: BSS, balanced salt solution; DTH, delayed-type hypersensi- 
tivity; FCS,  fetal calf serum; I-NDV,  infectious NDV; LA, lymphocyte agglutination; LMA, L. 
monocytogene  antigen; NANA, N-acetyl-neuraminic  acid; NDV, Newcastle disease virus; PBS, 
phosphate-buffered saline; PEC, peritoneal exudate cells; TDL, thoracic duct lymphocytes;  UV- 
NDV, ultraviolet-irradiated NDV; VSV, vesicular stomatitis virus. 
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Materials and Methods 
The influence of NDV on the tissue disposition and function of lymphecytes was measured by 
different but complementary techniques. First, TDL taken from rats infected with L. monocyto- 
genes  were radioactively labeled.  The  cells were  then  incubated  in  vitro with  NDV to  allow 
infection of susceptible cells and/or destruction of membrane receptors for NDV. Free virus was 
removed by washing before the cells were infused into similarly infected recipients. Localization of 
labeled  donor  lymphocytes  in  lymph  nodes  and  in  peritoneal  exudates  induced  by  killed L. 
monocytogenes  was  measured  radiometrically.  Second,  unlabeled  TDL,  incubated  with  NDV 
under identical conditions, were compared with untreated TDL in several assays of T-cell func- 
tion. 
Animals.  Male  and  female  (Lewis  ×  DA)F1  hybrid  rats  were  used  in  most  experiments; 
however, male Lewis rats were used in one experiment involving transfer of TDL into irradiated 
recipients. 
Cells and Tissues.  TDL were collected for 16-24 h into heparinized Ringer's solution without 
added antibiotics. Before labeling or infusion into recipient rats, the ceils were washed once with 
Hanks' balanced salt solution (BSS) containing 1% fetal calf serum (FCS). Peritoneal exudate cells 
(PEC) were obtained from rats stimulated intraperitoneally (i.p.) with 50 ~g of alcohol-killed L. 
monocytogenes  (8). 
Various lymph nodes were removed for radiometric analysis. The brachial and axillary Cso- 
matic") nodes were combined into a single pool. Mesenteric lymph nodes were assayed alone or in a 
pool of "visceral" nodes. These included the mesenteric, cecal, renal, and hepatic nodes. 
Radioactive  Labeling of TDL.  Lymphocytes in the  DNA synthetic  (S)  phase  of the mitotic 
cycle were labeled by incubating TDL in vitro for 1 h  in medium 199 containing 5% FCS, 1 U of 
heparin/ml,  and  [14C]thymidine  (40-60 mCi/mmol; New England Nuclear,  Boston,  Mass.)  at  a 
final concentration of 0.5  ~Ci/ml. The procedure labels 30-60% of immunoblasts; small lympho- 
cytes do not become labeled. 
Two  procedures  were  used  to  label  small  lymphocytes  preferentially.  In  one  experiment, 
prospective donors  of TDL  were  given a  single pulse  of vinblastine  (5  /~g/g),  a  drug  that  is 
selectively toxic for immunoblasts (9). Cells collected during the first 12 h of lymph drainage were 
incubated for 1 h  in medium containing 2  ~Ci/ml of [5-3H]uridine  (20 Ci/mmol, New England 
Nuclear). This procedure labels approximately 75% of small lymphecytes, but only T cells become 
heavily labeled (10,  11). In another experiment, TDL were obtained from rats 15 days after the 
animals had been given the last of 14 daily injections of [3H]thymidine  (3 Ci/mmol). During the 
"rest" interval, radioactivity becomes concentrated in small lymphocytes, both T and B, which 
have a potentially long life-span. 
Recipients  of labeled  TDL  were  injected  subcutaneously  (s.c.)  with  1  ml  of 0.85%  sodium 
chloride containing 25  ~g of the appropriate  unlabeled nucleoside(s).  In addition,  the animals 
were  offered "cold"  thymidine  (10 -3  M)  or  cold thymidine  and  cold uridine  (10 -3  M)  in  their 
drinking water beginning 48 h before cell transfer. 
Measurement  of Radioactivity.  l0  s  TDL,  PEC,  or  lymph  nodes  from  individual  rats  were 
extracted with 15 ml of ice-cold TCA. The insoluble pellet was washed twice with cold TCA. To 
each sample, 0.1 ml of hydrogen peroxide was added. The bleached pellet was then digested for 18 
h  at 50~C with 0.5-1.0 ml of normal calf serum solubilizer (Amersham/Searle Corp.,  Arlington 
Heights, Ill.). Thereafter the sample was neutralized with 0.2 ml of glacial acetic acid,  10 ml of 
PCS scintillant (Amersham/Searle Corp.) was added and the radioactivity measured in a  Beck- 
man liquid scintillation system (Beckman Instruments, Inc., Fullerton, Calif.). The radioactivity 
in PEC or lymph nodes of rats infused with labeled TDL was expressed  as percent counts per 
minute originally present in the donor inoculum. 
Autoradiography.  Air-dried smears of TDL were fixed in methanol and prepared as autoradi- 
ographs by a procedure described elsewhere (9). 
NDV.  The California strain of NDV was grown for 36-48 h in the allantoic cavity of 10-day-old 
embryonated eggs (Spafas, Inc., Norwich, Conn.). Infected allantoic fluid was clarified by centrif- 
ugation (500 g  ×  20 min). The virus was then concentrated  by centrifuging the fluid for 2 h  at 
100,000 g. Concentrated virus was stored up to 3 mo at -70°C without loss of activity as measured 
by lymphocyte agglutination, egg infectivity, or its capacity to destroy lymphocyte receptors for 
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Lymphocyte Agglutination.  Serial twofold dilutions  of NDV in 0.05 ml of PBS were dispensed 
into the wells of microtiter plates (Cooke Laboratory Products Div., Dynatech Laboratories Inc., 
Alexandria, Va.). An equal volume of phosphate-buffered saline (PBS) containing  3-12 × 10  ~  TDL 
was added to each well. After vigorous agitation, the cells were allowed to settle for 90 min at 4°C. 
The end point was expressed as the highest dilution of virus in which the TDL formed a uniform 
carpet on the floor of the well. A lymphocyte agglutination  (LA) unit was arbitrarily  defined as the 
concentration of virus which could agglutinate 107 TDL under the conditions described. 
Egg Infectivity.  The embryo infectivity dose (EIDs~) for embryonated eggs was calculated by 
the method of Reed and Muench (12). 
Ultraviolet Irradiation.  0.8 ml of NDV, diluted 1:8 in PBS, was dispensed into 35 x  10 mm 
Falcon dishes (BioQuest  Div., Becton, Dickinson & Co.,  Cockeysville,  Md.). The dishes were 
supported on a bed of crushed ice, placed on a rotating platform, and exposed for 10 min to UV 
irradiation from two G-15T8 germicidal lamps (Norelco, Lynn, Mass.). The latter, operating at a 
distance of 20 cm, delivered 25.8  x  103 ergs/mm  2 to the fluid-air interface. This large dose of 
irradiation inhibited  replication of NDV in eggs. However, irradiation did not impair the capacity 
of the virus to agglutinate TDL or its ability to destroy membrane receptors for NDV. 
Incubation of Lymphocytes with NDV.  TDL were washed once in BSS containing  1% FCS and 
resuspended at a  concentration of 33  ×  10  ~ cells/ml in PBS containing NDV.  The cells  were 
incubated for 30 rain at 4°C. Thereafter they were sedimented by centrifugation (500g  x  10 min), 
resuspended in virus-free medium 199 containing 1% FCS, and incubated an additional 60 min at 
37°C. Finally, the TDL were centrifuged from the medium and resuspended for i.v. transfer into 
recipient rats. When sugar was added to the incubation  mixture, the homologous sugar also was 
included in the medium with which the cells were washed. 
Sugars.  N-acetyl-neuraminic  acid (NANA) was obtained from BSehringer & Soehne, Mann- 
heim, Germany. L-fucose, D-galactose, D-mannose, N-acetyl-glucosamine,  andN-acetyl-galactosa- 
mine were purchased from Sigma Chemical Co., St. Louis, Mo. 
L. monocytogenes.  L. monocytogenes, strain EGD, was used for immunization  and challenge. 
A suspension of organisms prepared from a trypticase soy broth culture of infected mouse spleen 
was stored in liquid nitrogen and recovered  as needed. A soluble (L. monocytogene8 antigen 
(LMA)) was prepared from the organisms by a procedure described elsewhere (13). 
Antimicrobial Immunity.  The immunity  engendered in rats by S.C. injection  of approximately 
5  ×  10  ~ living L.  monocytogenes was measured indirectly, in terms of the specific resistance 
conferred on normal rats by an i.v. injection of 2 × 10" "immune" TDL/g of body weight (14). 
DTH.  Test subjects were given a single i.v. pulse of [3H]thymidine, 0.5 t~Ci/g. 24 h later, 1 t~g 
of LMA in 0.02 ml of saline and 0.02 ml of saline diluent were injected intradermally  into the pina 
of the right and left ears, respectively. 24 h later still, uniform biopsies (13) were removed from the 
injection sites. The ratio of counts per minute in the right ear biopsy to that in the left ear biopsy 
was expressed  as a "DTH index." 
Graft-vs.-Host Reaction.  The responsiveness of Lewis TDL to DA alloantigens was measured 
in vivo by a thymidine incorporation technique (15). 
Statistical Methods.  Differences between groups were evaluated by analysis of variance and 
the Q test (16). 
Results 
Influence  of I-NDV on the  Tissue Disposition of TDL.  [14C]thymidine was 
used to  label a  portion of immunoblasts  in the  thoracic duct lymph of 6-day 
Listeria-infected  donors. Small lymphocytes in the lymph of similarly infected 
rats were labeled with [5-aH]uridine, as described in the Material and Methods. 
The two  labeled cell populations were  then combined into a  single pool,  dis- 
pensed into culture flasks, and incubated briefly in medium containing various 
concentrations of I-NDV. Immediately thereafter the cells were washed and 2  × 
108 were transferred i.v. into each of 30 Listeria-infected  recipients. The TDL 
were  infused approximately 1  h  after the recipients had been stimulated i.p. 
with 50 t~g of killed L.  monocytogenes.  All were sacrificed 24 h  after transfer; 630 
~'-  k. 
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Cell-associated radioactivity in peritoneal exudates and lymph nodes from Liste- 
ria-infected rats 24 h after the animals had been infused with a mixture of [14C]thymidine- 
labeled immunoblasts and 5*~H-labeled small lymphocytes prepared from the thoracic duct 
lymph of similarly infected donors. The labeled cells were incubated in vitro with I-NDV 
immediately before transfer.  Whereas the virus readily diverted labeled donor immuno- 
blasts from exudates, relatively high concentrations were required to impede the accumula- 
tion of labeled small lymphocytes in lymph nodes. Means of 5 +-- SD. 
PEC were harvested  and two groups of lymph nodes removed for radiometric 
analysis. 
The results are shown in Fig.  1, where it can be seen that ~'C-labeled donor 
immunoblasts localized in substantial numbers in the exudates, whereas both 
labeled immunoblasts and 3H-labeled small lymphocytes were found in lymph 
nodes. The influx of labeled immunoblasts into exudates was readily inhibited 
by I-NDV. Witness the reduction in cell-associated ~4C after treatment of donor 
TDL with only 1 LA unit of virus. Higher virus multiplicities were required to 
impede  the  accumulation  of labeled  lymphocytes in  lymph  nodes.  Indeed,  a 
significant  (P  <  0.05) reduction  in cell-associated 3H in both mesenteric  and 
somatic nodes was observed only after treatment with 103 or 104 LA units. 
Inhibition of Listeria-Immune Lymphocytes by I-NDV.  The specific media- 
tors of resistance to L. monocytogenes have been identified as activated T cells 
(17-19). Since I-NDV can impede the exudate-seeking capacity of labeled immu- 
noblasts, and as the latter are mainly T cells (19), it was logical to postulate that 
protective cells in the thoracic duct lymph of  Listeria-immune rats would also be 
inhibited by virus. The results in Fig. 2 substantiate this notion insofar as they 
demonstrate  a  parallel  in  the  exudate-seeking  capacity  of labeled  S-phase 
lymphocytes and the ability of ~immune" TDL to protect recipient rats against 
an i.v. Listeria challenge. In each case, inhibition by I-NDV was proportional to 
the concentration of virus in the incubation mixture. 
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FIG.  2.  Curves showing the effect of various concentrations of I-NDV on the exudate- 
seeking capacity of labeled immunoblasts and the ability ofListeria-immune TDL to protect 
recipient rats against a Listeria challenge. Radioactivity in exudates harvested 24 h  after 
cell transfer (©--©)  is expressed  as percent counts per minute originally present in the 
donor inoculum. The protective activity of the donor cells (O--@) is expressed as the differ- 
ence in viable organisms in the spleens of individual cell recipients and the average bac- 
terial burden in a panel of nonimmunized controls sacrificed 48 h  after i.v. challenge with 
3.64  ×  l0  s L. monocytogenes.  Means of 5 +- SD. 
ferred Virus.  In the foregoing experiment, a small but unavoidable number of 
infectious virions were carried into rats at the time of cell transfer.  Therefore, 
the question arises  whether passenger virus can interact  with the recipient's 
own lymphocytes or macrophages in a manner that prevents full expression of 
cellular resistance to infection. The problem was studied by incubating Listeria- 
immune TDL in vitro with I-NDV,  50 LA units]109 cells. The TDL were then 
washed and added to an equal number of untreated lymphocytes from either the 
same Listeria-immune rats or from normal donors. It was reasoned that passen- 
ger virus might interact with other potentially vulnerable lymphocytes thereby 
abrogating their capacity to immunize adoptively. 
But this  was not the  case.  Table I  indicates  that  cell  mixtures  containing 
treated and untreated "immune" TDL conferred a full measure of immunity on 
the liver and only a  modestly low level of resistance on the spleen. Failure of 
passively transferred virus to inhibit untreated lymphocytes in the same inocu- 
lum makes it unlikely that it would compromise the immunological perform- 
ance of the recipient's own cells. 
Effect of  I-ND  V on the Mediator of  DTH.  TDL taken from rats at the peak of 
their  reponse  to  an  immunizing  infection  with L.  monocytogenes  can  confer 
DTH to LMA on normal recipients (13). The cells which do so are generated in 
response to infection and are thought to be linearly related if not identical with 
those  that  immunize  adoptively  (20).  Therefore,  it  was  pertinent  to  inquire 632  MEDIATOR  OF  CELLULAR  IMMUNITY.  XII 
TABLE  I 
Failure of Passenger Virus to Inhibit the Protective Capacity of Listeria-Immune TDL 
TDL inoculum* 
Log10 protections 
Liver  Spleen 
Immune (untreated) +  normal (untreated) 
Immune (untreated) +  immune (I-NDV) 
Normal (untreated) +  immune (I-NDV) 
2.03  2.80 
2.02  2.09 
-0.31  -0.12 
* Obtained  from 6-day Listeria-immune donors.  Cells  incubated in  vitro  in  either virus-free 
medium (untreated) or medium containing 50 LA units of I-NDV/10  s cells. The TDL were then 
combined in equal numbers with one another or with untreated TDL from normal, nonimmu- 
nized rats. Cell mixtures containing 4  ×  106 TDL/g of body weight were infused into syngeneic 
recipients 1 h  after the latter had been challenged i.v. with 3.27  ×  106L.  monocytogenes, 
S Mean difference 48 h  after challenge in viable Listeria in the tissues of five adoptively immu- 
nized subjects and five nonimmunized controls. 
TABLE  II 
Inhibition by I-NDV of SpecificaUy Sensitized Lymphocytes which 
Transfer DTH to LMA 
Test subjects  DTH index* 
Donors ofListeria-immune TDL  4.67  _+  1.65 
Recipients of 2  x  108 untreated TDL  2.17  _+  0.31 
Recipients  of  2 × 108 NDV-treated TDL$  1.10  +- 0.19 
* Means of 5 -+ SD. 
Incubated in vitro with 50 LA units of I-NDV/10  s cells. 
whether the cells responsible for transferring  DTH can be inhibited by I-NDV. 
Table II shows that an i.v. injection of 2 x  108 Listeria-immune TDL conferred a 
low but significant (P <  0.01) level of DTH on normal recipients, and that their 
ability to do so was abrogated by brief exposure to NDV in vitro. 
Failure of  I-NDV to Inhibit Antigen-Sensitive T Cells.  Antigen-sensitive T 
cells of the kind which initiate graft-vs.-host reactions are more resistant than 
activated T cells to the inhibitory influence of NDV. This conclusion was drawn 
from experiments in which the proliferative capacity of Lewis TDL was mea- 
sured in the spleens of heavily irradiated  (Lewis ×  DA)FI hybrid recipients. 
The results of a typical experiment are shown in Table HI where it can be seen 
that treatment  of the donor cells with I-NDV had little if any effect upon the 
level of [3H]thymidine incorporation in the spleen. Since the recipients had been 
irradiated  (850 rads),  it seems likely that  the proliferating  cells were mainly 
antigen-sensitive lymphocytes originally present in the donor inoculum (15). It 
is in keeping with this notion that a low level of  radioactivity was detected in the 
spleens of uninoculated F, rats and rats given TDL which had been incubated in 
vitro with mitomycin-C. 
Effect of UV-NDV on Listeria-Immune Lymphocytes.  It was of interest to 
determine whether the inhibitory influence of I-NDV on the protective function 
of Listeria-immune lymphocytes is related, in part, to the ability of the virus to 
replicate in susceptible cells. To test this proposition, immune TDL were incu- 
bated in vitro with I-NDV or UV-NDV. The TDL were then washed and infused D.  D.  McGREGOR,  P.  S.  LOGIE,  AND  L.  E.  CARMICHAEL 
TABLE  III 
Failure of LNDV to Inhibit the Proliferative  Capacity of Antigen-Sensitive 
L ymphocytes * 
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Treatment of donor TDL 
No. lymphocytes 
transferred x 
10-3/g 
Spleen cpm  x  10-35 
NDV§  100  492  -+ 112 
10  230 +- 45 
None  r~  100  617  _+ 151 
10  230  -  47 
0  19 ± 24 
Mitomycin-C¶  100  50 -+ 31 
* TDL from normal Lewis rats were infused into irradiated (850 rads) (Lewis  x 
DA)F, hybrid recipients. 
$ Cell-associated radioactivity in the spleen 4 days after cell transfer. The animals 
were sacrificed 1 h after an i.v. pulse of 1 t~Ci/g of [3H]thymidine. Means of 5 -+ SD. 
§ Incubated in vitro with 50 LA units of I-NDV/109 cells. 
" Incubated in virus-free medium. 
¶ Incubated in medium containing 50 ~g/ml of mitomycin-C. 
TABLE  IV 
Effect of UV Irradiation on the Capacity of  ND V to Inhibit the Protective Function 
of Listeria-Immune TDL 
Treatment of  NDV  Log,o protection§ 
donor TDL*  (EID.~o/ml)$  Liver  Spleen 
I-NDV  10  ~°'4  -0.44  -0.52 
UV-NDV  '1  < 10"°  2.59  1.44 
None  2.70  2.14 
* Cells from 6-day Listeria-immune donors were incubated in vitro in either virus-free 
medium (none) or medium containing 50 LA units of NDV/109 cells. 
$ Infectivity measured in 10-day embryonated eggs. 
§ Mean difference 48 h  after challenge in viable Listeria in the tissues of five adoptively 
immunized subjects and five nonimmunized controls. 
~' Irradiated (2.58 x  104 ergs/mm  2) immediately before addition to the culture. 
into  normal  recipients  immediately  after  the  latter  had  been  challenged  i.v. 
with 3.42  ×  106 L. monocytogenes. 
The results are shown in Table IV where it can be seen that I-NDV abrogated 
the protective power of the transferred  cells. By comparison, UV-NDV  had only 
a  modest inhibitory influence on the level of adoptive immunity  conferred on the 
spleen and none whatsoever  on resistance in the liver. 
Effect of UV-NDV on Lymphocyte Traffic.  A  double-labeling technique was 
used to mark  cohorts of dividing and  nondividing  lymphocytes  in the thoracic 
duct lymph of donor rats. The prospective donors were given 14 daily injections 
of [3H]thymidine  (0.5  tLCi/g).  9  days later,  the  animals  were  infected with L. 
monocytogenes. All were incannulated  on the 5th day of infection. Cells issuing 
from  the  fistulae  were  collected,  pooled,  and  incubated  in  vitro  with 634  MEDIATOR  OF  CELLULAR  IMMUNITY.  XII 
[~4C]thymidine. Autoradiographic analysis revealed that 97.7% of the cell-asso- 
ciated 3H was vested in small lymphocytes, whilst the '4C was concentrated in 
heavily labeled immunoblasts.  Cells doubly labeled in this manner were incu- 
bated in virus-free medium or in medium containing either I-NDV or UV-NDV. 
They were then washed and 2 × l0  s were infused into each of 90 Listeria-infected 
recipients. The cells were transferred immediately after the recipients had been 
stimulated i.p. with killed L. monocytogenes. 
Fig. 3 indicates that treatment with NDV had only a modest inhibitory effect 
upon the accumulation of 3H-labeled small lymphocytes in lymph nodes. Inhibi- 
tion was observed after treatment with either I-NDV or UV-NDV and was most 
conspicuous during the first 6 h  after cell transfer. 
But the two virus preparations had entirely different effects upon the localiza- 
tion in exudates of ~4C-labeled  immunoblasts.  Whereas  I-NDV virtually abol- 
ished  the  exudate-seeking  capacity of labeled immunoblasts,  treatment  with 
UV-NDV merely impeded their influx during the first few hours ai~r transfer 
(Fig.  4).  In  some  experiments  (results  not  shown)  treatment  with  UV-NDV 
failed to influence the final composition of the exudate, as judged by the level of 
radioactivity found at 24 h. These findings encourage the belief that UV-NDV 
has but a  transient  influence on immunoblast  traffic,  similar  to the effect of 
virus on the revivescent homing of small lymphocytes to lymph nodes. 
Effect of Deferred Stimulation  on Localization  of Labeled Immunoblasts  in 
Induced  Peritoneal  Exudates.  In  an  earlier  study  (21)  it  was  shown  that 
labeled S-phase TDL move in substantial numbers from the blood into Listeria- 
induced  exudates only during  the  early postinduction  period.  This  raises  the 
fascinating possibility that immunoblasts recover fully from changes induced by 
NDV but fail to localize in exudates because local changes in the microcircula- 
tion no longer favor their extravasation. To test this proposition, a TDL suspen- 
sion containing labeled immunoblasts was exposed briefly to I-NDV or UV-NDV 
before infusion into recipient rats. The latter were stimulated i.p. either at the 
time  of cell transfer  or 6,  12,  or 24  h  after transfer.  It was reasoned  that  if 
immunoblasts recover from the effects of virus treatment,  they would localize 
more efficiently in exudates induced several hours after transfer. 
The  results  in  Fig.  5  could be interpreted  in  this  way,  at least  insofar  as 
treatment  with  UV-NDV  is  concerned.  A  small  but  significant  (P  <  0.05) 
reduction  in radioactivity was observed in exudates borne by rats given UV- 
NDV-treated TDL, but only when the animals were stimulated i.p. at the time 
of cell transfer.  When stimulation was deferred,  similar levels of radioactivity 
were found in  animals  given  treated  or untreated  lymphocytes.  In  contrast, 
treatment  with I-NDV curtailed the influx of labeled immunoblasts into exu- 
dates regardless  of the interval  between cell transfer  and stimulation.  These 
findings give credence to the notion that NDV has at least two effects on S-phase 
lymphocytes.  One  effect is  related  in  some  way to  virus  adsorption  and  is 
mediated by I-NDV or UV-NDV. The other effect is irreversible and is mediated 
by infectious virus only. 
The Blocking Activity ofNANA.  NDV is one of several viruses which can 
bind to rat TDL (22). Adsorption is readily demonstrated at 4°C. But the virus- 
cell interaction  is unstable;  upon warming  to 37°C  virus elutes,  sialic acid is D.  D.  McGREGOR,  P.  S.  LOGIE,  AND  L.  E.  CARMICHAEL 
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FIG.  3.  Cell-associated radioactivity in the visceral lymph nodes of  Listeria-infected rats. 
The  animals had been infused with a  population of doubly labeled TDL from similarly 
infected donors (see text). Treatment of the donor cells in vitro with I-NDV (E]) or UV-NDV 
([]) impeded the homing of [~Hlthymidine-labeled small lymphocytes, but only during the 
first 6 h  after transfer. ThereaRer virus-treated cells accumulated in the nodes at approxi- 
mately the same rate as similarly labeled but otherwise untreated lymphocytes (11). Means 
of 5  -+ SD. 
released, and the cells cannot be agglutinated again by NDV (23). These events 
have been  ascribed  to  destruction of specific membrane receptors by  viral 
neuraminidase, and have been taken as evidence that the receptors terminate in 
sialic acid. It is in keeping with this hypothesis that NANA can block binding of 
NDV to rat TDL (22). Since the inhibitory influence of I-NDV is dependent upon 
its adsorption to susceptible cells, it is logical to postulate that virus-induced 
changes in T-lymphocyte  function would themselves be inhibited by NANA. 
The results in Table V substantiate this notion insofar as the exudate-seeking 
capacity of labeled S-phase lymphocytes is concerned. Likewise, Table VI shows 
that NANA can impede the interaction of  I-NDV with Listeria-immune TDL. 
The blocking effect of NANA is specific because other saccharides do not 
inhibit at the same molar concentration. Table VII indicates that of the various 
sugars and aminosugars added to the culture medium, NANA alone obstructed 
the interaction of I-NDV and Listeria-immune TDL. 
Blocking  of I-NDV  by  UV-NDV.  Since UV-NDV can destroy membrane 
receptors for the  virus,  it  was  pertinent to  inquire  whether such receptor- 
depleted lymphocytes enjoy a measure of resistance against I-NDV.  This possi- 
bility was tested by incubating Listeria-immune TDL in vitro with UV-NDV. 636  MEDIATOR  OF  CELLULAR  IMMUNITY.  XII 
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FIG.  4.  Cell-associated radioactivity in peritoneal exudates borne by the same groups of 
rats shown in Fig. 3.  [14C]thymidine-labeled immunoblasts originally present in the donor 
inoculum localized in substantial numbers in the exudates (I). Treatment of the donor cells 
with I-NDV ([3) virtually abolished their exudate-seeking capacity, whereas UV-NDV ([]) 
had only a modest inhibitory effect that was most conspicuous during the first 6-12 h  after 
transfer. Means of 5  -  SD. 
The  TDL  were then  washed and  resuspended  in fresh  virus-free  medium  or 
medium containing  I-NDV. After incubation for an additional 60 min at 37°C, 
the cells were tested for their capacity to protect recipient rats against an i.v. 
Listeria challenge. 
The results are summarized in Table VIII where it can be seen that UV-NDV 
had  a  modest  inhibitory  influence  upon  the  level  of immunity  conveyed by 
transferred  cells.  But TDL, treated initially with UV-NDV, were resistant  to 
further inhibition by a concentration of I-NDV that erased the protective power 
of untreated  lymphocytes.  The  results  could be  interpreted  in  several  ways; 
however,  they accord with  the view that  irradiated  virus can  cleave specific 
membrane receptors thereby preventing adsorption of I-NDV and replication of 
the virus in activated T cells (7). 
Discussion 
NDV  is  one  of the  several  viruses  which  can  adsorb  to  lymphocytes  and 
transiently interrupt their recirculation through lymph nodes and spleen (4-6). 
The phenomenon, first demonstrated by the Woodruffs (6) in experiments using 
51Cr-labeled TDL, was confirmed in the current study using either [5-3H]uridine 
or [3H]thymidine to selectively label small lymphocytes. Cells collected from the 
thoracic duct lymph of  Listeria-infected rats were exposed to NDV in vitro. After 
treatment with virus and infusion into recipient rats, labeled small lymphocytes 
were transiently deflected from lymph nodes. D.  D.  MCGREGOR,  P.  S.  LOGIE,  AND  L.  E.  CARMICHAEL  637 
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FIG.  5.  Cell-associated radioactivity in peritoneal exudates borne by Listeria-infected rats 
which had been infused with [14C]thymidine-labeled immunoblasts from the thoracic duct 
lymph of similarly infected donors. The exudates, induced at various intervals with respect 
to cell transfer, were harvested 24 h after stimulation. Treatment of the donor cells with I- 
NDV (E]) inhibited their exudate-seeking capacity regardless of the interval between cell 
transfer and stimulation. By comparison, treatment with UV-NDV (~) had only a modest 
inhibitory effect, and then only when exudates were induced at the time of cell transfer. The 
solid bars indicate the  accumulation in exudates of similarly labeled but otherwise un- 
treated immunoblasts. Means of 5 +_ SD. 
TABLE  V 
Blocking by NANA of the Interaction of I-NDV and Exudate- 
Seeking Immunoblasts* 
Concentration of NANA  Percent radioactivity 
in culture (pM/LA unit)  in exudate* 
0  0.11  ±  0.03 
10  o  0.15  +  0.06 
101  0.29 +  0.13 
l0  s  0.82  _+ 0.09 
103  1.77 ±  0.17 
0§  3.74 ±  0.50 
103"  3.95 _+ 0.83 
* Obtained  from  the  thoracic  duct  lymph  of  6-day Listeria-immune 
donors.  Cells incubated in vitro with I-NDV were infused into simi- 
larly infected recipients. The latter were stimulated i.p. at the time of 
cell transfer. 
$ Harvested 24 h  after stimulation. Means of 5  -+ SD. 
§ Incubated in virus-free medium. 
IJ Incubated in medium containing NANA but no virus. 638  MEDIATOR  OF  CELLULAR  IMMUNITY.  XII 
TABLE VI 
Blocking by NANA of the Interaction of I-NDV and Listeria- 
Immune TDL * 
Concentration of NANA  Loglo protection 
in culture (pM/LA unit)  (spleen)$ 
0  0.10 
10  o  -0.35 
101  -0.16 
102  1.25 
103  2.35 
0§  3.33 
10311  3.60 
* Obtained from 6-dayListeria-immune  donors. Cells incubated in vitro 
with I-NDV were infused into normal recipients 1 h after the recipi- 
ents had been challenged i.v. with 2.50 × 10  ~  L. monocytogenes. 
$ Mean difference 48 h after challenge in viableListeria in the spleens of 
five adoptively immunized subjects and five nonimmunized controls. 
§ Incubated in virus-free medium. 
~J Incubated in medium containing NANA but no virus. 
TABLE  VII 
Effects of Various Sugars on the Interaction of I-NDV and 
Listeria-Immune TDL * 
Sugar (50 ~M)  Log,o protection 
(spleen)$ 
L-fucose  -- 0.20 
v-mannose  0.02 
D-galactose  0.06 
N-acetyl-galactosamine  - 0.06 
N-acetyl-glucosamine  - 0.19 
N-acetyl-neuraminic acid  2.57 
None  0.11 
None§  3.36 
* Cells and I-NDV (50 LA units/109  TDL)  were incubated in vitro in 
medium containing various sugars. The cells were then washed and 
infused into normal recipients 1 h after the recipients had been chal- 
lenged i.v. with 2.85  ×  10~L. monocytogenes. 
$ Mean difference 48 h after challenge in viable  Listeria in the spleens of 
five adoptively immunized subjects and five nonimmunized controls. 
§ Incubated in virus-free medium. 
The  class(es)  of small  lymphocytes  affected  by  NDV  was  not  determined; 
however,  there  are reasons for thinking  that  virus-treated  T  cells are diverted 
from lymphoid  tissue  to  the  liver (4).  It is in keeping  with this view that  i.v. 
injection of NDV  into rats  or mice causes  rapid contraction of the circulating 
lymphocyte pool and depletion of small lymphocytes in areas of lymphoid tissue 
normally  occupied by T  cells (6). UV-NDV  and I-NDV are active in this regard. 
Furthermore,  both can block localization of labeled small lymphocytes in lymph D.  D.  McGREGOR,  P.  S.  LOGIE~  AND  L.  E.  CARMICHAEL  639 
TABLE  VIII 
Failure of  I-ND  V to Inhibit Listeriadmmune TDL after Treatment of  the Cells with UV- 
NDV* 
Treatment of donor TDL 
First incubation  Second incubation 
Loglo protections 
Liver  Spleen 
UV-NDV  None  1.33  1.27 
UV-NDV  I-NDV  1.61  1.88 
None  I-NDV  -0.59  -0.39 
None  None  1.89  2.27 
* TDL from 6-day Listeria-immune donors were incubated serially in virus-free medium (none) or 
medium containing either UV-NDV or I-NDV. Cells treated in this manner were infused into 
normal recipients 1 h after the recipients had been challenged i.v. with 2.83  ×  l(fL. monocyto- 
genes. 
$ Mean difference 48 h after challenge in number of viable Listeria in the tissues of five adoptively 
immunized subjects and five nonimmunized controls. 
nodes.  The  ability  of UV-NDV  to  inhibit  T-cell  homing  indicates  that  the 
migratory behavior of the cells does not depend upon the ability of the virus to 
achieve a  complete replication cycle in infected cells. 
A  novel aspect of this investigation was the demonstration that NDV  can 
interact with several classes of T cells as defined by their cytokinetics, tissue 
disposition, and immunological performance. Newly formed T cells, particularly 
those in active cycle, are especially vulnerable. Cells of  this type are delivered in 
increased numbers to the thoracic duct lymph of rats infected with L. monocyto- 
genes  (14).  The  cells have  a  low  density of surface immunoglobulin  (19),  a 
penchant to localize in inflammatory foci (21), and numbered among them are 
lymphocytes which can protect recipient rats against an i.v. Listeria challenge. 
In experiments using I-NDV, a precise and quantitative relationship was found 
between the  ability  of the virus to  impede the  exudate-seeking capacity of 
labeled S-phase lymphocytes and their protective power in adoptively immu- 
nized subjects (Fig. 2). 
The interaction of NDV with rat T cells is dependent upon attachment of the 
virus to  specific receptors on  the plasma  membrane.  These receptors either 
terminate  in  sialic  acid  or  are  so  positioned  that  sialic  acid residues  favor 
attachment of the virus.  Evidence to support this notion was obtained by the 
Woodruffs  (22). They demonstrated  that  agglutination  of TDL  by  NDV  is 
inhibited in medium containing NANA or fetuin, a  sialoglycoprotein. In the 
present investigation, it was shown that both exudate-seeking S-phase lympho- 
cytes and Listeria-immune TDL can be insulated by NANA against the inhibi- 
tory influence of infectious virus. These observations, taken in conjunction with 
the Woodruffs' findings (22), suggest that receptors for NDV are expressed on T 
cells regardless of size, state of activation, or their position in the mitotic cycle. 
Several lines of evidence indicate that NDV has at least two effects on T cells. 
One effect is related in some way to virus adsorption and is revealed in transient 
displacement of the cells from their usual traffic zones in the body. Both dividing 
and nondividing lymphocytes are affected. The influence on T-cell migration is 
reversible and is observed aider treatment with either I-NDV or UV-NDV. The 640  MEDIATOR  OF  CELLULAR  IMMUNITY.  XII 
second effect is irreversible and is mediated by infectious virus only; but the 
mechanism has not been determined. Nevertheless, it is logical to postulate that 
I-NDV has  a  lethal  effect on  activated T  cells,  because they alone support 
productive growth of  the virus (7). Interesting in this connection was the finding 
that UV-NDV can protect Listeria-immune  TDL against the inhibitory influ- 
ence of infectious virus. This seeming paradox could be explained if irradiated 
virus can destroy specific receptors on activated T cells, thereby preventing their 
infection and destruction by I-NDV. 
In any case, it is evident that T cells are not equally vulnerable. I-NDV can 
readily abrogate the protective power ofListeria-committed T cells. By compari- 
son, even high concentrations of virus have little if any impact upon prolifera- 
tion in the spleen of histocompatibility antigen-reactive T cells (Table III). The 
reasons for this  are  not  far to  seek  when it  is  remembered that  the  cells 
concerned are recirculating small lymphocytes, and that treatment with virus 
merely deflects them from the  spleen during the  first few hours  after i.v. 
transfer (4). 
Activated T cells do not belong to a  single, homogeneous class (18, 24-26). 
Therefore the question arises whether the cells inhibited by I-NDV belong to a 
particular subset as defined by morphological, cytokinetic, or functional crite- 
ria. The problem has been studied by Bloom and his associates in experiments 
using vesicular stomatitis virus (VSV). VSV can replicate in activated lympho- 
cytes and  inhibit  T-cell function in  vitro  and  in  vivo  (Nowakowski,  Kano, 
Bloom, Romano and Thorbecke, unpublished results). The cells supporting virus 
growth have been identified morphologically as '~large lymphocytes" (27), and 
functionally as T cells on the basis of their response to mitogens, inhibition by 
anti-Thy 1 serum, and failure to develop in cultures containing spleen cells from 
nude (athymic) mice (7, 28). An increase with time in virus plaque-forming cells 
was observed in cultures containing purified protein derivative of tuberculin 
and peripheral blood lymphocytes from tuberculin-sensitive human donors (29). 
The increase was linear and was unaffected by addition of vinblastine to the 
culture medium. This, and other evidence derived from studies of mixed lym- 
phocyte reactions (28), point to a nondividing T cell as the principal target of 
virus-induced suppression. 
NDV also can replicate in activated lymphocytes (30). However, the permis- 
sive cells have not been identified, nor has it been formally demonstrated that 
the immunosuppressive influence of I-NDV is related solely to virus growth and 
lysis of infected cells.  The fact that Listeria-immune  T  cells are especially 
vulnerable to NDV is interesting in this connection, because the cells are newly 
formed and  are  inhibited  by vinblastine  (9). I-NDV  also  can  abrogate  the 
protective power of TDL taken from rats infected with BCG; but suppression by 
virus is observed only when the cells are collected at an early stage of immuniza- 
tion and are in active cycle (McGregor, unpublished results). 
How can these findings be reconciled with the known capacity of VSV to 
replicate in nondividing lymphocytes (28, 29)? One possibility is that NDV and 
VSV inhibit different subsets of activated T cells. This can be proposed without 
prejudice to  the debate concerning the lineal  relationship of T-helper cells, 
cytotoxic T cells, and specifically sensitized lymphocytes  which collaborate with D.  D.  McGREGOR,  P.  S.  LOGIE,  AND  L.  E.  CARMICHAEL  641 
macrophages  in  the  expression  of DTH  and  cellular  resistance  to  infection. 
Alternatively, NDV and VSV might inhibit activated T cells regardless of their 
functional commitment,  provided the appropriate  conditions for virus replica- 
tion are satisfied.  According to this hypothesis, long-lived T  cells become per- 
missive  only  when  they  are  ~'stimulated"  in  vitro  by  specific  antigens  or  a 
polyclonal mitogen.  Further  stimulation  may not be necessary when the cells 
are newly formed or in active cycle. This is the case in Listeria-infected rats, in 
animals recently infected with BCG, and during the early phase of a graft-vs.- 
host reaction  (Nowakowski,  Kano,  Bloom,  Romano,  and  Thorbecke,  unpub- 
lished results). In any case, the ability of viruses to inhibit activated T cells has 
implications with respect to the host's defense against infection, virus-induced 
immunosuppression,  and possibly certain immunopathological sequelae of viral 
disease (3, 31). 
Summary 
Newcastle disease virus (NDV) can interact in at least two ways with rat T 
cells. By adsorbing to circulating lymphocytes, the virus can transiently deflect 
the cells from lymph nodes and inflammatory exudates induced in the peritoneal 
cavity. T  cells are affected regardless of age, state of activation,  or position in 
the mitotic cycle. The effect is reversible and is mediated not only by infectious 
(I)-NDV,  but  also by UV-NDV which  cannot  achieve  a  complete replication 
cycle in eggs.  But I-NDV has another lasting  effect on activated T  cells. It is 
revealed in  the  failure  of virus-treated  thoracic duct lymphocytes to transfer 
cellular resistance to Listeria monocytogenes, delayed-type hypersensitivity to 
soluble antigens of the parasite, and the permanent exclusion of labeled S-phase 
lymphocytes from inflammatory  foci. Activated T  cells are inhibited by virus 
multiplicities which have little if any effect upon the proliferative potential of 
antigen-sensitive T  cells or localization of labeled small lymphocytes in lymph 
nodes. The underlying mechanism has not been determined; however, there are 
reasons for thinking that NDV has a lethal effect upon activated T cells, because 
the latter are permissive for virus replication. 
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